SELLAS Life Sciences
SLS
SLS
20 hedge funds and large institutions have $5.1M invested in SELLAS Life Sciences in 2018 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 6 increasing their positions, 1 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
33% more funds holding
Funds holding: 15 → 20 (+5)
0.11% more ownership
Funds ownership: 0.26% → 0.38% (+0.11%)
Holders
20
Holding in Top 10
–
Calls
$166K
Puts
$4K
Top Buyers
| 1 | +$769K | |
| 2 | +$547K | |
| 3 | +$318K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$140K |
| 5 |
BlackRock
New York
|
+$129K |
Top Sellers
| 1 | -$96K | |
| 2 | -$21K | |
| 3 | -$16K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$13K |
| 5 |
MAM
Meeder Asset Management
Dublin,
Ohio
|
-$4.94K |